Announced
Completed
Financials
Tags
Pharmaceuticals
Management Consulting
Completed
Private
Natural
United States
Merger
pharmaceutical consulting
Single Bidder
Synopsis
IMS Health and Quintiles Transnational, pharmaceutical consulting companies has completed a merger. “This combination addresses life-science companies’ most pressing needs: to transform the clinical development of innovative medicines, demonstrate the value of these medicines in the real world, and drive commercial success. We are bringing together two best-in-class leaders. I’m confident that together we will make our clients even more successful.” Tom Pike, Quintiles Chief Executive Officer.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.